BB BIOTECH AG - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of EXELIXIS INC
ValueSharesWeighting
Q1 2019$67,473,000
+21.0%
2,835,0000.0%1.70%
-5.1%
Q4 2018$55,764,000
+13.0%
2,835,000
+1.8%
1.79%
+36.8%
Q3 2018$49,350,000
+116.3%
2,785,000
+162.7%
1.31%
+98.2%
Q2 2018$22,811,0001,060,0000.66%
Other shareholders
EXELIXIS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Meditor Group Ltd 3,138,200$68,569,67088.89%
Krensavage Asset Management, LLC 1,899,151$41,49615.28%
Caligan Partners LP 910,730$19,899,4519.14%
13D Management LLC 479,728$10,482,0576.52%
PSquared Asset Management AG 1,422,745$31,086,9782.84%
FARALLON CAPITAL MANAGEMENT LLC 25,860,000$565,041,0002.83%
Merlin Capital, Inc 24,641$538,4062.01%
CAPITAL MANAGEMENT CORP /VA 364,684$7,968,3451.80%
Lingohr Asset Management GmbH 31,493$6881.78%
Seaport Global Advisors, LLC 26,071$569,6511.71%
View complete list of EXELIXIS INC shareholders